Literature DB >> 19369646

Acrosomal swelling and membrane docking are required for hybrid vesicle formation during the human sperm acrosome reaction.

Natalia Zanetti1, Luis S Mayorga.   

Abstract

Acrosomal exocytosis in mammalian sperm is a regulated secretion with unusual characteristics. One of its most striking features is the loss of the outer acrosomal membrane and the overlying plasma membrane as hybrid vesicles. We have reported previously in human sperm that by preventing the release of calcium from the acrosome, the exocytic process can be arrested at a stage where SNARE proteins are assembled in loose trans complexes. Transmission electron micrographs of sperm at this stage showed that the acrosomes were profusely swollen, with deep invaginations of the outer acrosomal membrane. The protruding edges of these invaginations were tightly apposed (i.e., docked) to the plasma membrane. Docking was prevented when streptolysin O-permeabilized sperm were stimulated in the presence of tetanus toxin or botulinum neurotoxin C, two SNARE-specific proteases. We propose that SNAREs present in the plasma membrane interact with SNAREs in the protruding edge of cup-shaped invaginations of the outer acrosomal membrane to form trans complexes. Fusion pore opening and expansion in this ring of apposed membranes would generate the hybrid vesicles that are released during the acrosome reaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369646     DOI: 10.1095/biolreprod.109.076166

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  28 in total

1.  Redistribution of the intra-acrosomal EGFP before acrosomal exocytosis in mouse spermatozoa.

Authors:  Noritaka Hirohashi; Florenza A La Spina; Ana Romarowski; Mariano G Buffone
Journal:  Reproduction       Date:  2015-04-01       Impact factor: 3.906

2.  Human spermatozoa possess a calcium-dependent chloride channel that may participate in the acrosomal reaction.

Authors:  Gerardo Orta; Gonzalo Ferreira; Omar José; Claudia L Treviño; Carmen Beltrán; Alberto Darszon
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

Review 3.  Unresolved questions concerning mammalian sperm acrosomal exocytosis.

Authors:  Mariano G Buffone; Noritaka Hirohashi; George L Gerton
Journal:  Biol Reprod       Date:  2014-03-26       Impact factor: 4.285

4.  The Rab3A-22A Chimera Prevents Sperm Exocytosis by Stabilizing Open Fusion Pores.

Authors:  María F Quevedo; Ornella Lucchesi; Matías A Bustos; Cristian A Pocognoni; Paola X De la Iglesia; Claudia N Tomes
Journal:  J Biol Chem       Date:  2016-09-09       Impact factor: 5.157

5.  RIM, Munc13, and Rab3A interplay in acrosomal exocytosis.

Authors:  Oscar D Bello; M Natalia Zanetti; Luis S Mayorga; Marcela A Michaut
Journal:  Exp Cell Res       Date:  2012-01-10       Impact factor: 3.905

Review 6.  Heads or tails? Structural events and molecular mechanisms that promote mammalian sperm acrosomal exocytosis and motility.

Authors:  Mariano G Buffone; Takashi W Ijiri; Wenlei Cao; Tanya Merdiushev; Haig K Aghajanian; George L Gerton
Journal:  Mol Reprod Dev       Date:  2011-10-26       Impact factor: 2.609

Review 7.  The eggstraordinary story of how life begins.

Authors:  John Parrington; Christophe Arnoult; Rafael A Fissore
Journal:  Mol Reprod Dev       Date:  2018-11-30       Impact factor: 2.609

8.  Munc18-1 controls SNARE protein complex assembly during human sperm acrosomal exocytosis.

Authors:  Facundo Rodríguez; M Natalia Zanetti; Luis S Mayorga; Claudia N Tomes
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

9.  How pig sperm prepares to fertilize: stable acrosome docking to the plasma membrane.

Authors:  Pei-Shiue Tsai; Núria Garcia-Gil; Theo van Haeften; Bart M Gadella
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

Review 10.  K+ and Cl- channels and transporters in sperm function.

Authors:  C M Santi; G Orta; L Salkoff; P E Visconti; A Darszon; C L Treviño
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.